A mucus-based prophylactic gel developed at KTH Royal Institute of Technology in Stockholm, Sweden has proven 70 percent effective in lab tests against HIV, and 80 percent effective against herpes. The viral prophylactic tests were conducted in a lab on several types of cells. The results were reported on September 16, 2022 in Advanced Science. The open-access article is titled “Synthetic Mucin Gels with Self-Healing Properties Augment Lubricity and Inhibit HIV-1 and HSV-2 Transmission.” Lead-author Hongji Yan (photo), PhD, a biomaterials researcher at KTH, says the promising results raise hope that, when it becomes available as a product, the gel could help reverse troubling trends in HIV spread.
Login Or Register To Read Full Story